The value and generalizability of cost-effectiveness research.

J Thorac Cardiovasc Surg

Division of Cardiac and Thoracic Surgery, Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, Va.

Published: April 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2017.12.064DOI Listing

Publication Analysis

Top Keywords

generalizability cost-effectiveness
4
generalizability
1

Similar Publications

The oxidation of 5-HMF to HMFCA is an important yet complex process, as it generates high-value chemical intermediates. Achieving this transformation efficiently requires the development of non-precious, highly active catalysts derived from renewable biomass sources. In this work, we introduce UoM-1 (UoM, University of Mazandaran), a novel cobalt-based metal-organic framework (Co-MOF) synthesized using a simple one-step ultrasonic irradiation method.

View Article and Find Full Text PDF

No cost-effectiveness information of preventive strategies for mother-to-child transmission (MTCT) of hepatitis B virus (HBV) has existed for policy decision making. This study aimed to compare the cost-effectiveness of alternative strategies to prevent MTCT of HBV in Vietnam. Cost-utility analysis using a hybrid decision-tree and Markov model were performed from healthcare system and societal perspectives.

View Article and Find Full Text PDF

Background: Fall prevention programmes are essential interventions in societies with aging populations. This study assessed the fall rate and other health outcomes, as well as the cost-effectiveness of a home-based fall prevention programme for community-dwelling older people. In a single home visit, trained physical or occupational therapists performed fall risk assessments, eliminated environmental risk factors, and provided tailored exercises.

View Article and Find Full Text PDF

Objectives: Chronic myeloid leukemia (CML) management now includes dose-reduction (DR) and treatment-free remission (TFR). Evaluating cost-effectiveness of lifelong-prescribed expensive tyrosine kinase inhibitors (TKIs) for CML is crucial. Prior cost-effectiveness evaluations state that imatinib is the favorable frontline TKI.

View Article and Find Full Text PDF

Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines.

Vaccine

December 2024

Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA. Electronic address:

Background: The economic and public health benefits of adult pneumococcal vaccines vary across countries due to different epidemiology and costs. We systematically reviewed and summarized findings and assumptions of cost-effectiveness analyses (CEA) of the recently introduced 15- and 20-valent pneumococcal conjugate vaccines (PCV15 and PCV20) in adults.

Methods: We performed a systematic search for CEA studies of PCV15 and/or PCV20 versus existing strategies via PubMed, EMBASE, CEA Registry, EconLit, HTA Database, and NITAG resource center through April 23, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!